Article
Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation
2022-06-17
Abstract excerpt
<h4>SUMMARY</h4> Multiple system atrophy (MSA) is a neurodegenerative disease showing accumulation of misfolded α-synuclein and myelin disruption. However, the mechanism how α-synuclein (α-syn) accumulate in MSA brain remains unclear. Here, we identify the protein epsin-2 as a novel target for MSA therapy via controlling α-synuclein accumulation. In MSA mouse model, PLP-hαSyn transgenic mice and FABP7/α-syn heter...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- da4532f7-b1c5-5461-9c4a-9f7862857504
- DOI
- 10.1101/2022.06.16.496509
